Valuation : Sanofi

Market Cap 87.77B 102B 83.1B 75.3B 141B 9,725B 142B 986B 379B 4,943B 382B 374B 15,557B P/E 2026 *
11.7x
P/E 2027 * 10.2x
Enterprise Value 99.23B 115B 93.95B 85.13B 160B 10,995B 160B 1,115B 429B 5,589B 432B 423B 17,589B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.9x
Free-Float
88.34%
Yield 2026 *
5.81%
Yield 2027 * 6.14%
1 day-0.31%
1 week-3.99%
Current month-4.28%
1 month-3.01%
3 months-4.86%
6 months-3.60%
Current year-10.84%
1 week 19
Extreme 19
19.46
1 month 19
Extreme 19
20.47
Current year 18.8
Extreme 18.8
22.02
1 year 18.8
Extreme 18.8
22.57
3 years 18.8
Extreme 18.8
22.57
5 years 18.8
Extreme 18.8
22.57
10 years 18.8
Extreme 18.8
22.57
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer - 2026-08-31
Director TitleAgeSince
Director/Board Member 61 2019-04-29
Director/Board Member 57 2020-04-27
Director/Board Member 65 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.31%-3.99% - - 102B
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+28.24%+35.57% 337B
-0.09%-13.54%+10.08%+26.87% 261B
-0.43%-2.48%-2.07%+11.48% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.08%-59.58% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.68%-5.76%+21.42%+40.80% 389.42B
Weighted average by Cap. -0.50%-4.42%+30.47%+55.25%

Financials

2026 *2027 *
Net sales 47.65B 55.25B 45.11B 40.88B 76.64B 5,279B 77.05B 535B 206B 2,684B 208B 203B 8,446B 50.64B 58.73B 47.95B 43.45B 81.46B 5,611B 81.9B 569B 219B 2,852B 221B 216B 8,977B
Net income 7.48B 8.67B 7.08B 6.41B 12.02B 828B 12.09B 83.99B 32.3B 421B 32.56B 31.84B 1,325B 8.87B 10.28B 8.4B 7.61B 14.27B 983B 14.34B 99.64B 38.32B 499B 38.63B 37.77B 1,572B
Net Debt 11.46B 13.29B 10.85B 9.83B 18.44B 1,270B 18.54B 129B 49.54B 646B 49.93B 48.82B 2,032B 8.34B 9.67B 7.89B 7.15B 13.41B 924B 13.48B 93.66B 36.02B 469B 36.31B 35.5B 1,478B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-09-11 $19.00 -0.31% 410
26-09-10 $19.06 -0.42% 1,000
26-09-09 $19.14 -1.24% 1,522
26-09-08 $19.38 -2.07% 2,270
26-09-04 $19.79 -0.30% 125
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
73.26EUR
Average target price
94.06EUR
Spread / Average Target
+28.39%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!